000 | 01794 a2200505 4500 | ||
---|---|---|---|
005 | 20250514164118.0 | ||
264 | 0 | _c20040217 | |
008 | 200402s 0 0 eng d | ||
022 | _a0019-2805 | ||
024 | 7 |
_a10.1111/j.1365-2567.2004.01768.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aOzegbe, Patricia | |
245 | 0 | 0 |
_aImpact of cAMP on the T-cell response to type II collagen. _h[electronic resource] |
260 |
_bImmunology _cJan 2004 |
||
300 |
_a35-40 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_a8-Bromo Cyclic Adenosine Monophosphate _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntigen-Presenting Cells _ximmunology |
650 | 0 | 4 |
_aArthritis, Experimental _xdrug therapy |
650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aCholera Toxin _xtherapeutic use |
650 | 0 | 4 |
_aColforsin _xtherapeutic use |
650 | 0 | 4 |
_aCollagen Type II _ximmunology |
650 | 0 | 4 |
_aCyclic AMP _xmetabolism |
650 | 0 | 4 |
_aDinoprostone _xtherapeutic use |
650 | 0 | 4 | _aEnzyme Activation |
650 | 0 | 4 |
_aInterferon-gamma _xbiosynthesis |
650 | 0 | 4 |
_aInterleukin-4 _xbiosynthesis |
650 | 0 | 4 |
_aInterleukin-5 _xbiosynthesis |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred DBA |
650 | 0 | 4 | _aModels, Animal |
650 | 0 | 4 |
_aPhosphodiesterase Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aRolipram _xtherapeutic use |
650 | 0 | 4 |
_aSecond Messenger Systems _xphysiology |
650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
700 | 1 | _aFoey, Andrew D | |
700 | 1 | _aAhmed, Salman | |
700 | 1 | _aWilliams, Richard O | |
773 | 0 |
_tImmunology _gvol. 111 _gno. 1 _gp. 35-40 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2567.2004.01768.x _zAvailable from publisher's website |
999 |
_c14410557 _d14410557 |